Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price: ₹2,496.30
Market cap: ₹1,03,108 Cr
Revenue (annual): ₹14,278 Cr
Net profit (annual): ₹1,913 Cr
P/E (TTM): 50.5×Sector 47.4×
Promoter holding: 72.63%-0.03% QoQ
FII holding: 9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Other Announcement 2 Management Change 2 Employee Stock Options 2 Annual General Meeting 2 Share Pledge 1 Partnership 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

1 Sep 2026 17:59 IST BSE

Employee Stock Options

Mankind Pharma Employee Stock Options

Mankind Pharma has allotted 49,112 equity shares under its ESOP Plan 2022 to eligible employees upon exercise of options. The allotment increases its paid-up share capital.

Value: ₹4.22 Cr

Read the filing ↗

1 Sep 2026 17:54 IST NSE

Employee Stock Options

Mankind Pharma Employee Stock Options

Mankind Pharma has allotted 49,112 equity shares under its ESOP scheme. This allotment increases the paid-up share capital by Rs. 49,112 in face value.

Read the filing ↗